pharmacopeia
GET
/api/v1/drug/bacitracin

Mechanism of action

Sourced from openFDA

Mechanism-of-action classes: Cell Membrane Fusion Complex Interactions; Enzyme Interactions.

Indications

Sourced from openFDA
  • Uses first aid to help prevent infection in: • minor cuts • scrapes • burns

Dosage & administration

Sourced from openFDA

Directions • clean the affected area • apply a small amount of this product (an amount equal to the surface area of the tip of a finger) on the area 1 to 3 times daily • may be covered with a sterile bandage

Warnings & precautions

Sourced from openFDA

For external use only Do not use • in the eyes • over large areas of the body • if you are allergic to any of the ingredients Ask a doctor before use if you have • deep or puncture wounds • animal bites • serious burns Stop use and ask a doctor if • you need to use longer than 1 week • condition persists or gets worse • rash or other allergic reaction develops Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Approval history

Sourced from openFDA
  • Jan 26, 1995ANDAANDA064046Bausch And Lomb Inc
  • Oct 30, 1995ANDAANDA064064Bausch And Lomb Inc
  • Oct 30, 1995ANDAANDA064068Bausch And Lomb Inc

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
4,370 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Drug Hypersensitivity3959.0%
  2. 2Drug Ineffective2696.2%
  3. 3Pain2365.4%
  4. 4Nausea2325.3%
  5. 5Dyspnoea2195.0%
  6. 6Diarrhoea2134.9%
  7. 7Fatigue2044.7%
  8. 8Rash2024.6%
  9. 9Off Label Use1723.9%
  10. 10Headache1633.7%
  11. 11Dizziness1623.7%
  12. 12Anxiety1563.6%
  13. 13Pyrexia1563.6%
  14. 14Vomiting1543.5%
  15. 15Pneumonia1473.4%

Literature

View JSON

Recent PubMed references pinned to Bacitracin as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 52 ClinicalTrials.gov registrations naming Bacitracin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Bacitracin work?
Mechanism-of-action classes: Cell Membrane Fusion Complex Interactions; Enzyme Interactions.
What is Bacitracin used for?
According to FDA labeling, Bacitracin carries indications including: Uses first aid to help prevent infection in: • minor cuts • scrapes • burns. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Bacitracin?
Bacitracin is classified as Antibiotics, Other antibacterials, Other antibiotics for topical use, Cell Membrane Fusion Complex Interactions, Enzyme Interactions, Decreased Cell Wall Synthesis & Repair.
What are the brand names for Bacitracin?
Bacitracin is marketed under brand names including Baciguent, Bactine Antibiotic, Cuadriderma, Lanabiotic, Mycitracin Plus Pain Reliever, Neo-Polycin, Neo-Polycin HC, Polycin.
Note. Data for bacitracin is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients